WebApr 13, 2024 · On average, equities analysts forecast that MoonLake Immunotherapeutics will post -1.27 EPS for the current year. Insider Activity at MoonLake Immunotherapeutics. In other MoonLake Immunotherapeutics news, major shareholder Bihua Chen purchased 588,589 shares of the company’s stock in a transaction that occurred on Monday, March … WebWhat is GNLX's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors. Price-To-Book vs Fair Ratio: Insufficient data to calculate GNLX's Price-To-Book Fair Ratio for valuation analysis. Share Price vs Fair Value
ChatGPT is better at predicting how stocks will react to news headlines t…
WebForecast Price target 10.00 0.00 0.00% The 1 analyst offering 1 year price forecasts for GNLX have a max estimate of — and a min estimate of —. Analyst rating Based on 1 … WebGNLX Stock 12 Months Forecast $10.00 (-62.63% Downside) Based on 1 Wall Street analysts offering 12 month price targets for Genelux Corp. in the last 3 months. The … change days season 1 cast
Genelux Corporation Common Stock (GNLX) SEC Filings Nasdaq
WebApr 6, 2024 · GNLX Stock Chart & Stats Advanced Chart > $27.29 $3.14 (13.00%) At close: Mar 17 4:00 PM EDT ― Day’s Range $0 - $0 52-Week Range $5.35 - $39.27 Previous … WebApr 7, 2024 · Latest Genelux Corp Stock News As of March 31, 2024, Genelux Corp had a $727.6 million market capitalization, putting it in the 61st percentile of companies in the Biotechnology & Medical Research industry. Genelux Corp does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Web2 days ago · A study found ChatGPT was pretty good at determining how news headlines could affect stock prices. Florida researchers asked ChatGPT to analyze the sentiment … harding place to go